Swiss officials: Covid vaccine protects for 12 months
Coronavirus vaccines could offer at least 12 months of protection against all forms of the virus, a top Swiss health official says. This increases the former official line of six months of protection.
The Federal Vaccination Commission has concluded that people are protected for at least a year against infection – and more than that against severe cases, said Virginie Masserey, head of the Federal Office of Public Health’s Infectious Diseases Section, at a press conference on Tuesday.
It will therefore not be necessary to have a booster jab before 2022, she added.
Ordinances on the issue will be changed to reflect this change of view.
More than half of adults have already received at least one dose of the vaccine, Masserey explained. This rises to at least 80% for vulnerable groups. The vaccination campaign is proceeding well, with around 100,000 vaccinations a day, the official said. There are no indications that vaccine willingness is dropping off.
Covid certificate
The development of the forgery proof Covid certificate is also going well, with more than 650,000 already sent out, Masserey said. “We are confident that all those who want can have access to a certificate by the end of the month,” she said. This is to be given to anyone who has been vaccinated, has recovered from or has recently tested negative for coronavirus. The validity length of the certificate would also be changed due to the protection advice change.
Trend, variants
Meanwhile downward trend in case numbers is continuing. There were 243 reported Covid-19 casesExternal link on Tuesday, 14 hospitalisations and two deaths. New infections have stayed below 1,000 since May 26.
Masserey added that until now the number of cases linked to new variants of the coronavirus like the Delta variant were relatively low. Vaccines were also effective against these variants, but people still had to be careful as not everyone had yet been vaccinated, she added
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
International cooperation: the National Assembly accepts 11 billion euros
This content was published on
Switzerland's international cooperation strategy 2025-2028 has been recommended a budget of almost CHF11 billion after weeks of political wrangling.
Zurich court throws out ‘cum-ex’ case against German lawyer
This content was published on
A trial against a German lawyer, accused of breaching Swiss banking secrecy investigating 'cum-ex' transactions, has collapsed.
Swiss National Bank lowers key interest rate by 0.5%
This content was published on
The Swiss National Bank lowers benchmark interest rate by a surprisingly hefty 0.5%. The reference rate now stands at 0.5%.
Swiss fintech Leonteq has profits confiscated after regulatory breach
This content was published on
Swiss derivatives firm Leonteq acted in serious violation of regulatory obligations and must to hand over CHF9.3 million in profits.
This content was published on
US-based biotech company Moderna is applying for the use of its Covid-19 vaccine for adolescents aged 12 to 17 in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.